Matthias Clauss
- Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research 24
- Immunology top 1%
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 11
- Protease and Inhibitor Mechanisms 7
- Clinical Biochemistry top 0.5%
- Microbiology top 0.5%
-
- Angiogenesis and VEGF in Cancer 37
-
- HIV-related health complications and treatments 11
-
- Blood Coagulation and Thrombosis Mechanisms 9
-
- Pulmonary Hypertension Research and Treatments 8
-
- HIV Research and Treatment 7
- Co-authors
- Werner RisauGeorg BreierJ BrettUlrike E. KniesMarlene L. GerlachHerbert A. WeichWolfgang SchäperMatthias Grell
- Journals
- Cell (1 paper)Proceedings of the National Academy of Sciences (3 papers)Journal of Biological Chemistry (8 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Matthias Clauss
105 papers receiving 9.1k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Immunology and Allergy 730
- Immunology 2.4k
- Cancer Research 1.5k
- Clinical Biochemistry 644
- Microbiology 561
Countries citing papers authored by Matthias Clauss
This map shows the geographic impact of Matthias Clauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Clauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Clauss more than expected).
Fields of papers citing papers by Matthias Clauss
This network shows the impact of papers produced by Matthias Clauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Clauss. The network helps show where Matthias Clauss may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthias Clauss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2021 | 5 | |
| 3 | Extracellular vesicles: novel communicators in lung diseases | 2020 | 2 |
| 4 | 2020 | 16 | |
| 5 | 2018 | 40 | |
| 6 | Role of tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and associated proteins in coronary artery disease and cardiac events | 2017 | 1 |
| 7 | 2017 | 26 | |
| 8 | Endogenous Transmembrane TNF-Alpha Protects Against Premature Senescence in Endothelial Colony Forming Cells | 2016 | 1 |
| 9 | 2014 | 26 | |
| 10 | 2012 | 17 | |
| 11 | 2012 | 15 | |
| 12 | 2006 | 58 | |
| 13 | 2006 | 61 | |
| 14 | Temporal Development of Choroidal Neovascularization (CNV) in the Rat Laser Trauma Model | 2005 | 1 |
| 15 | 2004 | 38 | |
| 16 | 2003 | 36 | |
| 17 | 2003 | 1 | |
| 18 | 2001 | 19 | |
| 19 | 2001 | 34 | |
| 20 | 1991 | 4 |
About Matthias Clauss
Matthias Clauss is a scholar working on Immunology and Allergy, Cancer Research and Virology, having authored 107 papers that have together received 9.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (37 papers), Cell Adhesion Molecules Research (24 papers), HIV-related health complications and treatments (11 papers), Cancer, Hypoxia, and Metabolism (11 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers), Pulmonary Hypertension Research and Treatments (8 papers), Protease and Inhibitor Mechanisms (7 papers) and HIV Research and Treatment (7 papers). The work is most often cited by research in Immunology and Allergy (730 citations), Immunology (2.4k citations) and Cancer Research (1.5k citations). Matthias Clauss has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Werner Risau, Georg Breier, J Brett, Ulrike E. Knies, Marlene L. Gerlach, Herbert A. Weich, Wolfgang Schäper, Matthias Grell, J Kao and Wolfgang Röckl. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.